Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Juan J. Díez"'
Autor:
Juan J. Díez, Pedro Iglesias
Publikováno v:
European Journal of Endocrinology. 170:R147-R157
Tumor-induced hypoglycemia (TIH) is a rare clinical entity that may occur in patients with diverse kinds of tumor lineages and that may be caused by different mechanisms. These pathogenic mechanisms include the eutopic insulin secretion by a pancreat
Publikováno v:
European Journal of Endocrinology. 167:301-309
Fibroblast growth factor 21 (FGF21), a 181 amino acid circulating protein, is a member of the FGF superfamily, with relevant metabolic actions. It acts through the interaction with specific FGF receptors and a cofactor called β-Klotho, whose express
Autor:
Pedro Iglesias, Juan J. Díez
Publikováno v:
European Journal of Endocrinology. 160:503-515
Thyroid hormones (TH) are essential for an adequate growth and development of the kidney. Conversely, the kidney is not only an organ for metabolism and elimination of TH, but also a target organ of some of the iodothyronines' actions. Thyroid dysfun
Autor:
Juan J. Díez, Pedro Iglesias
Publikováno v:
European Journal of Endocrinology. 154:613-621
Type 2 diabetes is a well recognised cause of chronic renal failure (CRF). Only few oral antidiabetic drugs can be used for treating type 2 diabetes in patients with CRF. Among them are repaglinide, a rapid-acting prandial insulin releaser, and perox
Autor:
Juan J. Díez, Pedro Iglesias
Publikováno v:
European Journal of Endocrinology. :293-300
Adiponectin, also called GBP-28, apM1, AdipoQ and Acrp30, is a novel adipose tIssue-specific protein that has structural homology to collagen VIII and X and complement factor C1q, and that circulates in human plasma at high levels. It is one of the p
Publikováno v:
European journal of endocrinology. 167(3)
Fibroblast growth factor 21 (FGF21), a 181 amino acid circulating protein, is a member of the FGF superfamily, with relevant metabolic actions. It acts through the interaction with specific FGF receptors and a cofactor called β-Klotho, whose express
Publikováno v:
European journal of endocrinology. 143(2)
OBJECTIVE: Our aim has been to evaluate the effects of i.v. infusion of recombinant human erythropoietin (rhEPO) on the responses of growth hormone (GH), prolactin (PRL) and thyrotropin (TSH) to thyrotropin-releasing hormone (TRH) stimulation in acro